Rufinamide
Use
Monitoring serum rufinamide concentrations, assessing patient adherence, and guiding dosage adjustments in patients receiving drugs that interact pharmacokinetically with rufinamide (e.g., CYP3A4 inducers); also useful for patients undergoing hemodialysis.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
3-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red top tube or serum separator tube; accept lavender (K2/K3 EDTA) or SST
Collection Instructions
Collect blood immediately before next scheduled dose; for sustained-release formulations, collect a minimum of 12 hours after last dose; centrifuge and aliquot serum into plastic vial within 2 hours.
Storage Instructions
Refrigerated preferred; ambient and frozen acceptable.
Causes for Rejection
Whole blood; gel separator tubes; light blue (citrate); yellow (SPS or ACD solution)